- Home
- BOLT
as 12-18-2024 3:32pm EST
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 25.3M | IPO Year: | 2021 |
| Target Price: | $1.25 | AVG Volume (30 days): | 168.8K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.50 - $1.56 | Next Earning Date: | 11-12-2024 |
| Revenue: | $9,779,000 | Revenue Growth: | 35.86% |
| Revenue Growth (this year): | 9.87% | Revenue Growth (next year): | -46.43% |
Latest Bolt Biotherapeutics Inc. News
BOLT Breaking Stock News: Dive into BOLT Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations
Zacks
a month ago
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates
Associated Press Finance
a month ago
Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot
GlobeNewswire
a month ago
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Simply Wall St.
a month ago
Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation
GlobeNewswire
a month ago
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
GlobeNewswire
3 months ago
Bolt Biotherapeutics Announces Changes to its Board of Directors
GlobeNewswire
4 months ago
Bolt Biotherapeutics to Participate in Upcoming September Conferences
Compare BOLT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BOLT Bolt Biotherapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.